Influence of Orlistat on the Regulation of Gallbladder Contraction in Man: A Randomized Double-Blind Placebo-Controlled Crossover Study

Digestive Diseases and Sciences

Volumn 41, Issue 12, 1996, Pages 2404-2408

  Froehlich, F ^a   Hartmann, D ^b   Guezelhan, C ^b   Gonvers, J J ^b   Jansen, J B M J ^b   Fried, M ^b  

^a POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^b NONE

Author keywords

Cholecystokinin; Gallbladder motility; Lipase inhibitor; Orlistat; Tetrahydrolipstatin

Indexed keywords

CHOLECYSTOKININ; GASTRIN; PANCREAS POLYPEPTIDE; PLACEBO; TETRAHYDROLIPSTATIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GALLBLADDER CONTRACTION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AREA UNDER CURVE; CHOLECYSTOKININ; CROSS-OVER STUDIES; DIETARY FATS; DOUBLE-BLIND METHOD; FASTING; FEMALE; GALLBLADDER EMPTYING; GASTRINS; HUMANS; LACTONES; LIPASE; MALE; PANCREATIC POLYPEPTIDE; REFERENCE VALUES;

EID: 0030481873     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02100135     Document Type: Article

References (28)

1. Hadvary P, Lengsfeld, Wolfer H: Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin. Biochem J 256:357-361, 1988
2. Borgstrom B: Fat digestion and absorption. In Biomembranes, DH Smith (ed). London, Plenum Press, 1974, Vol 4B
3. Fernandez E, Borgstrom B: Effects of tetrahydrolipstatin, a lipase inhibitor, on absorption of fat from the intestine of the rat. Biochim Biophys Acta 1001:249-255, 1989
4. Hogan S, Fleury A, Hadvary P, Lengsfield H, Meier MK, Triscari J, Sullivan AC: Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipase. Int J Obes 11(Suppl):35-42, 1987
5. Hauptman JB, Jeunet FS, Hartmann D: Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin). Am J Clin Nutr 55:309S-313S, 1992
6. Meier MK, Blum-Kaelin D, Bremer K, Isler D, Joly R, Keller-Rupp P, Lengsfield H: Preclinical profile of the lipase inhibitor tetrahydrolipstatin (Ro 18-0647, THL), a potential drug for the treatment of obesity. Int J Obes 15(Suppl):31, 1991
7. Drent ML, van der Veen EA: Lipase inhibition: A novel concept in the treatment of obesity. Int J Obesity 17:241-244, 1993
8. Cantor P, Petronijevic L, Pedersen JF, Worning H: Cholecystokinetic and pancreozymic effect of o-sulfated gastrin compared with nonsulfated gastrin and cholecystokinin. Gastroenterology 91:1154-1163, 1986
9. Hopman WPM, Kerstens PJSM, Jansen JBMJ, Rosenbusch G, Lamers CBHW: Effect of graded physiologic doses of cholecystokinin on gallbladder contraction measured by ultrasonography - determination of threshold, dose-response relationships and comparison with intraduodenal bilirubin output. Gastroenterology 90:1247-1247, 1985
10. Fried M, Erlacher U, Schwizer W, Löchner C, Koerfer J, Beglinger C, Jansen JB, Lamers CB, Harder F, Bischof-Delaloye A, Stalder GA, Rovati L: Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Gastroenterology 101:503-511, 1991
11. Meyer BM, Beglinger C, Jansen JBMJ, Rovati LC, Werth BA, Hildebrand P, Zach D, Dtalder GA: Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 2:12-15, 1989
12. Forgacs IC, Maisey MN, Murphy GM, Dowling RH: Influence of gallstones and ursodeoxycholic acid therapy on gallbladder emptying. Gastroenterology 87:299-307, 1984
13. La Morte WW, Schoetz DJ, Birkett DH, Williams LF: The role of the gallbladder in the pathogenesis of cholesterol gallstones. Gastroenterology 77:580-592, 1979
14. Thompson JC, Fried GM, Ogden WD, Facan CJ, Inoue K, Wiener I, Watson LC: Correlation between release of cholecystokinin and contraction of the gallbladder in patients with gallstones. Ann Surg 195:670-675, 1982
15. Festi D, Frabboni R, Bazzoli F: Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology 99:1779-1785, 1990
16. Meyer FD, Gyr K, Häcki WH, Beglinger C, Jeker K, Varga L, Kayasseh L, Gillessen D, Stalder GA: The release of pancreatic polypeptide by CCK-octapeptide and some analogues in the dog. Gastroenterology 80:742-747, 1981
17. Beglinger C, Hildebrand P, Meier R, Bauerfeind P, Haslocher H, Urscheler N, Delco F, Eberle A, Gyr K: A physiological role for cholecystokinin as a regulator of gastrin secretion. Gastroenterology 103:490-495, 1992
18. Schmidt WE, Schenk S, Nustede R, Holst JJ, Fölsch UR, Creutzfeld W: Cholecystokinin is a negative regulator of gastric acid secretion and postprandial release of gastrin in humans. Gastroenterology 107:1610-1620, 1994
19. Everson GT, Braverman DZ, Johnson ML, Kern F: A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology 79:40-46, 1980
20. Jansen JBMJ, Lamers CBHW: Radioimmunoassay of cholecystokinin in human plasma and tissue. Clin Chim Acta 131:305-316, 1983
21. Jansen JBMJ, Lamers CBHW: Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome. Gastroenterology 83:173-178, 1982
22. Hartmann D, Hussain Y, Güzelhan C, Odink J: Effect on dietary fat absorption of orlistat, administered at different times relative to meal intake. Br J Clin Pharmacol 36:266-270, 1993
23. Jones B, Kenward MG (eds): Design and Analysis of Crossover Trials. London/New York, Chapman and Hall, 1989
24. Stone BG, Ansel HJ, Peterson FJ, Gebhard RL: Gallbladder emptying stimuli in obese and normal-weight subjects. Hepatology 15:795-798, 1992
25. Fried M, Schwizer W, Froehlich F, Güzelhan G, Jansen JBMJ. Lamers CBHW, Gonvers JJ, Blum AL, Hartmann D: Role of lipase in the regulation of upper gastrointestinal functions in man. Studies with THL, a new highly specific lipase inhibitor. Gastroenterology 100:A272, 1991
26. Fried M, Schwizer W, Asal K, Güzelhan C, Jansen JBMJ, Lamers CBHW, Blum AL, Gonvers JJ, Hartmann D: Role of lipase in the regulation of upper gastrointestinal functions in man: Nutrient specific effects - studies with THL, a new highly specific lipase inhibitor. Gastroenterology 102:A266, 1992
27. Meyer JH, Hlinka M, Jehn D, Gu YG: Preduodenal mechanisms compensate completely for absent pancreatic enzymes to stimulate gallbladder after meals. Dig Dis Sci 40:739-744, 1995
28. 14C-labelled orlistat in healthy volunteers. Pharmacol Res 10(Suppl):S335, 1993